Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (201-210 of 399) with videos related to

Pageof 40
Sort By:
Atherosclerosis|June 20, 2014
Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout miceAnna M D Watson, Jiaze Li, Dian Samijono, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?Geoffrey Boner, Alison J Cox, Darren J Kelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsAnna C Calkin, Josephine M Forbes, Craig M Smith, et al.
Nephron. Physiology|January 31, 2004
A study of VEGF and its receptors in two rat models of proteinuriaJohn Kanellis, Vicki Levidiotis, Tiffany Khong, et al.
Diabetologia|June 22, 2019
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouseJay C Jha, Aozhi Dai, Chet E Holterman, et al.
Journal of Hypertension|March 6, 2012
An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trialsPaul A Smink, Stephan J L Bakker, Gozewijn D Laverman, et al.
Diabetes|October 27, 2004
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathwayVicki Thallas-Bonke, Carsten Lindschau, Bishoy Rizkalla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2013
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?Jamie Morton, Martin K C Ng, John Chalmers, et al.
Journal of the American Heart Association|July 2, 2018
Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE TrialMerlin C Thomas, Mark Woodward, Qiang Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mousePhyllis Chew, Derek Y C Yuen, Philip Koh, et al.
Pageof 40

Showing results (201-210 of 399) with videos related to

Sort By:
Pageof 40
Atherosclerosis|June 20, 2014
Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout miceAnna M D Watson, Jiaze Li, Dian Samijono, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?Geoffrey Boner, Alison J Cox, Darren J Kelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsAnna C Calkin, Josephine M Forbes, Craig M Smith, et al.
Nephron. Physiology|January 31, 2004
A study of VEGF and its receptors in two rat models of proteinuriaJohn Kanellis, Vicki Levidiotis, Tiffany Khong, et al.
Diabetologia|June 22, 2019
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouseJay C Jha, Aozhi Dai, Chet E Holterman, et al.
Journal of Hypertension|March 6, 2012
An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trialsPaul A Smink, Stephan J L Bakker, Gozewijn D Laverman, et al.
Diabetes|October 27, 2004
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathwayVicki Thallas-Bonke, Carsten Lindschau, Bishoy Rizkalla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2013
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?Jamie Morton, Martin K C Ng, John Chalmers, et al.
Journal of the American Heart Association|July 2, 2018
Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE TrialMerlin C Thomas, Mark Woodward, Qiang Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mousePhyllis Chew, Derek Y C Yuen, Philip Koh, et al.
Pageof 40